diabetes drugs

2. insulin, metformin, and glyburide are the safest diabetes drugs in _____-
3. GLP-1 agonists and SGLT-2 inhibitors should be USED in patients with __________ disease
5. DPP4 inhibitors bind to and prevent the _____ of GLP-1
7. episodes insulin, sulfonylureas, and meglitinides should be avoided if there are frequent_____-
8. GLP-1 agonists are mimetics of what kind of hormones?
10. what diabetes drug inhibits hepatic gluconeogenesis the most?
14. hepatocytes and pancreatic B cells uptake flucose using ______# receptors
15. this drug is used to prepare for pheochromocytoma surgery and is a beta blocker
16. detemir and glargine are _____-_____ insulin which do not have "peaks"
18. a common side effect of SGLT2 inhibitors are frequent ____
20. what kind of diabetes drugs should be avoided in heart failure?
23. used for a suppression test if pheochromocytoma is suspected
25. SGLT2 inhibitors block glucose _______ by the ________
26. GLP-1 agonists and gliptins are effective treatment for patiets with problematic _____ _____
27. Other than insulin, the drugs that are most likely to cause hypoglycemia are ...

1. what DM drug can cause lactic acidosis with high anion gap?
4. meglitinides work like ________
6. pramlintide is an analog of ______
9. what drug slows gastric emptyinh?
11. SGLT2 inhibitors block glucose _(previous question) _ by the ________
12. what drug inhibits carbohydrate absorption?
13. Other than insulin, the drugs that are most likely to cause hypoglycemia are ...
17. GLP-1 agonists have been found to be most effective for _____ ______
19. what drug (-suffix) increases GLUT4 expression on liver and adipose tissue
21. GLUT 4 is the receptor that uptakes glucose in _____ and skeletal muscle
22. what drug causes fat malabsorption (and is NOT indicated for diabetes?)
24. sulfonylureas close ATP-sensitive _______ channels on pancreatic beta cells, increasing insulin release